Uncategorized
Bevacizumab effect in diabetic macular edema sustained at two years
NEW YORK (Reuters Health) - A study conducted at Moorfields Eye Hospital in London, UK, finds that the
benefits seen at one year with bevacizumab treatment of macular edema are sustained at two years, with
comparatively few intravitreal injections.